New Results
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Jungang Chen, Lu Dai, Lindsey Barrett, Steven R. Post, Zhiqiang Qin
doi: https://doi.org/10.1101/2020.10.02.324228
Jungang Chen
1Departments of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR 72205, USA
Lu Dai
1Departments of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR 72205, USA
Lindsey Barrett
1Departments of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR 72205, USA
Steven R. Post
1Departments of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR 72205, USA
Zhiqiang Qin
1Departments of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W Markham St, Little Rock, AR 72205, USA

Article usage
Posted October 02, 2020.
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Jungang Chen, Lu Dai, Lindsey Barrett, Steven R. Post, Zhiqiang Qin
bioRxiv 2020.10.02.324228; doi: https://doi.org/10.1101/2020.10.02.324228
Subject Area
Subject Areas
- Biochemistry (8831)
- Bioengineering (6536)
- Bioinformatics (23493)
- Biophysics (11818)
- Cancer Biology (9235)
- Cell Biology (13350)
- Clinical Trials (138)
- Developmental Biology (7453)
- Ecology (11431)
- Epidemiology (2066)
- Evolutionary Biology (15183)
- Genetics (10458)
- Genomics (14057)
- Immunology (9193)
- Microbiology (22222)
- Molecular Biology (8833)
- Neuroscience (47670)
- Paleontology (352)
- Pathology (1432)
- Pharmacology and Toxicology (2493)
- Physiology (3741)
- Plant Biology (8098)
- Synthetic Biology (2226)
- Systems Biology (6046)
- Zoology (1258)